Ticker Details
ARS Pharmaceuticals, Inc.
IPO Date:	December 4, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$821.19M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 2.93%
Avg Daily Range (30 D):	$0.22 | 2.61%
Avg Daily Range (90 D):	$0.28 | 2.80%

Institutional Daily Volume
Avg Daily Volume:	1.04M
Avg Daily Volume (30 D):	1.26M
Avg Daily Volume (90 D):	1.28M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	834
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$1.5M
Avg Institutional Trade (90 D):	$1.46M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.82M
Avg Closing Trade (30 D):	$1.76M
Avg Closing Trade (90 D):	$1.67M
Avg Closing Volume:	163.39K

News

Nov 10, 2025 @ 11:00 AM ARS Pharmaceuticals Reports Third Quarter 2025 Fin... Source: Ars Pharmaceuticals

Aug 13, 2025 @ 7:04 PM ARS Pharma Sales Jump 3,040% in Q2 Source: Jesterai

Jan 6, 2025 @ 1:00 PM ARS Pharmaceuticals Files for Approval of neffyÂÂ... Source: N/A

Dec 13, 2024 @ 9:58 PM ARSファーマシューã... Source: N/A

Dec 13, 2024 @ 9:58 PM ARS Pharmaceuticals 宣布在中å›Â... Source: Ars Pharmaceuticals, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.74	$-.42	$-1.74
Diluted EPS	$-1.74	$-.42	$-1.74
Revenue	$84.28M	$28.09M	$84.28M
Gross Profit
Net Income / Loss	$-171.3M	$-41.32M	$-171.3M
Operating Income / Loss	$-179.45M	$-41.47M	$-179.45M
Cost of Revenue
Net Cash Flow	$-9.5M	$-18.24M	$-9.5M
PE Ratio